The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
Open accessAbstract
Human T-cell leukemia and T-cell acute lymphoblastic leukemia cell lines were studied for alterations in the p53 tumor suppressor gene. Southern blot analysis of 10 leukemic T-cell lines revealed no gross genomic deletions or rearrangements. Reverse transcription-polymerase chain reaction analysis of p53 mRNA indicated that all 10 lines produced p53 mRNA of normal size. By direct sequencing of polymerase chain reaction-amplified cDNA, we detected 11 missense and nonsense point mutations in 5 of the 10 leukemic T-cell lines studied. The mutations are primarily located in the evolutionarily highly conserved regions of the p53 gene. One of the five cell lines in which a mutation was detected possesses a homozygous point mutation in both p53 alleles, while the other four cell lines harbor from two to four different point mutations. An allelic study of two of the lines (CEM, A3/Kawa) shows that the two missense mutations found in each line are located on separate alleles, thus both alleles of the p53 gene may have been functionally inactivated by two different point mutations. Since cultured leukemic T-cell lines represent a late, fully tumorigenic stage of leukemic T cells, mutation of both (or more) alleles of the p53 gene may reflect the selection of cells possessing an increasingly tumorigenic phenotype, whether the selection took place in vivo or in vitro. Previously, we have shown that the HSB-2 T-cell acute lymphoblastic leukemia cell line had lost both alleles of the retinoblastoma tumor suppressor gene. Taken together, our data show that at least 6 of 10 leukemic T-cell lines examined may have lost the normal function of a known tumor suppressor gene, suggesting that this class of genes serves a critical role in the generation of fully tumorigenic leukemic T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
Gyllensten, U. B., & Erlich, H. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7652 · Cited by 1,560
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,197
Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia
Foley, G. E., Lazarus, H., Farber, S., Uzman, B. G., Boone, B. A., & McCarthy, R. E. (1965) · Cancer · doi:10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j · Cited by 1,171
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., & Levine, A. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.531 · Cited by 1,144
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/49.3.891 · Cited by 916
Sarnow, P., Ho, Y. S., Williams, J., & Levine, A. J. (1982) · Cell · doi:10.1016/0092-8674(82)90356-7 · Cited by 836
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation
Parada, L. F., Land, H., Weinberg, R. A., Wolf, D., & Rotter, V. (1984) · Nature · doi:10.1038/312649a0 · Cited by 730
DeLeo, A. B., Jay, G., Appella, E., Dubois, G. C., Law, L. W., & Old, L. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.5.2420 · Cited by 721
Participation of p53 cellular tumour antigen in transformation of normal embryonic cells
Eliyahu, D., Raz, A., Gruss, P., Givol, D., & Oren, M. (1984) · Nature · doi:10.1038/312646a0 · Cited by 717
Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 692
Minowada, J., ONUMA, T., & Moore, G. E. (1972) · PubMed · Cited by 646
P53 expression in breast cancer
Cattoretti, G., Rilke, F., Andreola, S., D'Amato, L., & Delia, D. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410204 · Cited by 601
A regulatory hierarchy for cell specialization in yeast
Herskowitz, I. (1989) · Nature · doi:10.1038/342749a0 · Cited by 590
Hinds, P., Finlay, C., & Levine, A. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.739-746.1989 · Cited by 577
Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53
Jenkins, J. R., Rudge, K., & Currie, G. A. (1984) · Nature · doi:10.1038/312651a0 · Cited by 552
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.
Oren, M., Maltzman, W., & Levine, A. J. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.2.101 · Cited by 489
Yokota, J., Wada, M., Shimosato, Y., Terada, M., & Sugimura, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9252 · Cited by 480
Rearrangement of the p53 gene in human osteogenic sarcomas.
Masuda, H., Miller, C., Koeffler, H. P., Battifora, H., & Cline, M. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7716 · Cited by 474
Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas
Gazdar, A., Carney, D., Bunn, P., Russell, E., Jaffe, E., Schechter, G., & Guccion, J. (1980) · Blood · doi:10.1182/blood.v55.3.409.409 · Cited by 442
Wolf, D., & Rotter, V (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.790 · Cited by 410
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.
Rogel, A., Popliker, M., Webb, C. G., & Oren, M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2851 · Cited by 378
Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.
Reich, N. C., Oren, M., & Levine, A. J. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.12.2143 · Cited by 312
Ahuja, H., Bar-Eli, M., Advani, S. H., Benchimol, S., & Cline, M. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6783 · Cited by 284
Mitotic recombination of chromosome 17 in astrocytomas.
James, C. D., Carlbom, E., Nordenskjold, M., Collins, V. P., & Cavenee, W. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2858 · Cited by 279
A variation in the structure of the protein-coding region of the human p53 gene
Buchman, V. L., Chumakov, P. M., Ninkina, N. N., Samarina, O. P., & Georgiev, G. P. (1988) · Gene · doi:10.1016/0378-1119(88)90196-5 · Cited by 278
ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS
Mackay, J., Elder, P., Steel, C. M., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90584-3 · Cited by 236
Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.
Zakut-Houri, R., Bienz-Tadmor, B., Givol, D., & Oren, M. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03768.x · Cited by 218
When the products of oncogenes and anti-oncogenes meet
Green, M. R. (1989) · Cell · doi:10.1016/0092-8674(89)90975-6 · Cited by 198
The cellular oncogene p53 can be activated by mutagenesis
Jenkins, J. R., Rudge, K., Chumakov, P., & Currie, G. A. (1985) · Nature · doi:10.1038/317816a0 · Cited by 169
Rotter, V. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2613 · Cited by 161
Adams, R., Flowers, A., & Davis, B. J. (1968) · PubMed · Cited by 157
Immortalization of rat embryo fibroblasts by the cellular p53 oncogene.
Rovinski, B., & Benchimol, S. (1988) · PubMed · Cited by 153
Kelman, Z., Prokocimer, M., PELLER, S., Kahn, Y., Rechavi, G., Manor, Y. S., Cohen, A., & Rotter, V. (1989) · Blood · doi:10.1182/blood.v74.7.2318.2318 · Cited by 151
Mashal, R. D., Shtalrid, M., Talpaz, M., Kantarjian, H., Smith, L., Beran, M., Cork, A., Trujillo, J., Gutterman, J. U., & Deisseroth, A. (1990) · Blood · doi:10.1182/blood.v75.1.180.180 · Cited by 141
Ben David, Y., Prideaux, V. R., Chow, V., Benchimol, S., & Bernstein, A. (1988) · PubMed · Cited by 127
Cytogenetic Study of Human Lymphoid T -Cell Lines Derived From Lymphocytic Leukemia 2
Huang, C. C., Hou, Y., Woods, L. K., Moore, G. E., & Minowada, J. (1974) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.655 · Cited by 110
The cellular protein p53 in human tumours.
Crawford, L. V., Pim, D. C., & Lamb, P. (1984) · PubMed · Cited by 104
Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes
Mercer, W. E., & Baserga, R. (1985) · Experimental Cell Research · doi:10.1016/0014-4827(85)90233-2 · Cited by 92
Increased expression of p53 protein in human leukemia cells.
Koeffler, H. P., Miller, C., Nicolson, M. A., Ranyard, J., & Bosselman, R. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4035 · Cited by 84
p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression.
Lübbert, M., Miller, C. W., Crawford, L., & Koeffler, H. P. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.3.873 · Cited by 82
Establishment of the DU.528 human lymphohemopoietic stem cell line.
Kurtzberg, J., Bigner, S. H., & Hershfield, M. S. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.5.1561 · Cited by 74
Energy requirement for degradation of tumor-associated protein p53.
Gronostajski, R. M., Goldberg, A. L., & Pardee, A. B. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.3.442 · Cited by 73
Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line
Cheng, J. Y., Scully, P., Shew, J., Lee, W., Vila, V., & Haas, M. (1990) · Blood · doi:10.1182/blood.v75.3.730.730 · Cited by 70
Self-citationExpression of the p53 oncogene in acute myeloblastic leukemia.
Smith, L. J., McCulloch, E. A., & Benchimol, S. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.3.751 · Cited by 52
Soussi, T., Caron de Fromentel, C., Stürzbecher, H. W., Ullrich, S., Jenkins, J., & May, P. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3894-3901.1989 · Cited by 26
Drexler, H. G., & Minowada, J. (1989) · Hematological Oncology · doi:10.1002/hon.2900070203 · Cited by 19
(1988) · PubMed
Cited by
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
A role for sunlight in skin-cancer – UV-induced p53 mutations in squamous-cell carcinoma
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., & Pontén, J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10124 · Cited by 1,959
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Gaidano, G., Ballerini, P., Gong, J. Z., Inghirami, G., Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D. M., & Dalla-Favera, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5413 · Cited by 885
Metadata
- Authors
- Cheng, J., & Haas, M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1990-10
- Volume
- 10
- Issue
- 10
- Pages
- 5502-5509
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2164697719
- Cited by
- 316
- References
- 55
- FWCI
- 9.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.